Featured Listing

AlphaMaven

Company Logo'

Venture Capital Featured Listing

BrookDell Partners

Back

Venture Capital

Andrea Alms Video: Money In Motion 17 - Discovering A Hot Investment Spot - Digital Biotech

August 2022 - Venture Capital

posted by BrookDell Partners
2yrs ago

Transcript:


Hello. My name is Andrea Alms and I am technology investor and financial manager and this is your money in motion. I was asked about biotech and drug investing. As a tech investor, I wonder, isn't the future of biotech digital? In order to do so? Let's check out the top leading causes of death. According to CDC, the 2020 data shows. Heart, cancer, COVID and so on are the leading causes. Since most of us all know of and most familiar with. Let's focus on heart, cancer and diabetes, which are highlighted in yellow with the growing adoption of novel digital disease management tools and technologies. What I call the future of biotech is digital. I began my search of the digital biotech markets. As you all know, my favorite markets are multibillion and double digit growth. Here is what I uncovered so far. Digital cardiovascular market. The cardio Vascular Digital Solutions Market is expected to witness a growth rate of 12% between 2021 and 2028 and is expected to reach 159 billion by 2028. The rise in the prevalence of cardiovascular diseases globally is escalating. The growth of this cardiovascular digital solutions market, the digital solutions market is referring to the integration and use of digital technologies such as software, wearables, sensors, smartphones, AI and virtual healthcare solutions. Let's look at the digital cancer market oncology information system, market size is valued at 7 billion in 2021 and is expected to reach 13 billion by 2030 at a compound average growth rate of 7%. Oncology information system is a software that is designed to handle and maintain different patient profiles across the health care centers such as clinics, hospitals and research laboratories. It aims at improving efficiency, connecting different disciplines of oncology and ensuring optimal use of resources to support efficient workflow. Indian Ecology Center. Okay, let's now check out the digital diabetes management market. That size is expected to grow and has exceeded 15 billion in 2021 and is projected to grow to 20%. Average compound growth rate between 2022 and 2030. Increasing number of diabetes patients across the globe will benefit the adoption of digital diabetes management services and products. For instance, per the International Diabetes Federation, nearly 463 million people are living with diabetes. Globally in 2019, the need for continuous monitoring of blood glucose among these patients will highly impact this market growth. So we uncovered another billion dollar market and double digit growth. Top in size is digital cardiovascular. Top and growth rate is diabetes. Overall, winner of this round is the digital cardiovascular market. Let's keep our eye on these. Thank you. This is your money, your money in motion.


ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.